Clinical Trials Browser

Phase 2 × Interventional × Neoplasm Recurrence, Local × Clear all

NCT06942416 2025-04-24

Iparomlimab and Tuvonralimab With Chemoradiation for the Treatment of Locally Recurrent and Oligometastatic Cervical Cancer

Phase 2 Recruiting

Uterine Cervical Neoplasms, Neoplasm Recurrence, Local, Neoplasms

NCT00095225 2008-01-29

A Study to Evaluate Bevacizumab and Chemotherapy or Tarceva in Treating Recurrent or Refractory NSCLC (Non-Small Cell Lung Cancer)

Phase 2 Completed

Carcinoma, Non-Small-Cell Lung, Neoplasm Recurrence, Local, Recurrence